CISEN PHARMACEUTICAL CO., LTD.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference c9aa1dbaab
Drug names138First applicant · distinct drug namesAcceptance records199First applicant · distinct acceptance numbersUnder-review numbers50First applicant · current under-review listCo-applicant records20Subsequent applicant only · separate count
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/11 06:42.
Drug filings
199 acceptance records as first applicant, grouped into 138 source drug names. Source data as of 2026/11/11 06:42.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
Adefovir Dipivoxil Tablets 2 records · Latest accepted 2026/10/21
Supplement · 2
Pioglitazone Hydrochloride Tablets 2 records · Latest accepted 2026/09/18
Generic · 2
Tranexamic Acid Injection 2 records · Latest accepted 2026/09/17
Generic · 2
Loratadine Tablets 1 records · Latest accepted 2026/08/20
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2602061 | Generic | 2026/08/20 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Iopromide Injection 1 records · Latest accepted 2026/07/29
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601825 | Generic | 2026/07/29 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Azithromycin For Injection 1 records · Latest accepted 2026/07/23
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2650165 | Supplement | 2026/07/23 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
No verified English name 2 records · Latest accepted 2026/07/17
Generic · 2
Baricitinib Tablets 2 records · Latest accepted 2026/07/16
Generic · 2
Metformin Hydrochloride Tablets 1 records · Latest accepted 2026/07/06
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601595 | Generic | 2026/07/06 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Peramivir Injection 1 records · Latest accepted 2026/07/01
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601554 | Generic | 2026/07/01 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Ioversol Injection 2 records · Latest accepted 2026/06/18
Generic · 2
Isosorbide Mononitrate Extended-Release Tablets 1 records · Latest accepted 2026/05/18
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601170 | Generic | 2026/05/18 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Iomeprol Injection 1 records · Latest accepted 2026/05/11
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601074 | Generic | 2026/05/11 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Ambroxol Hydrochloride Tablets 1 records · Latest accepted 2026/05/06
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601025 | Generic | 2026/05/06 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Multiple Electrolytes Injection 1 records · Latest accepted 2026/04/20
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600897 | Generic | 2026/04/20 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Carboplatin Injection 2 records · Latest accepted 2026/04/03
Generic · 2
Selexipag Tablets 2 records · Latest accepted 2026/03/20
Generic · 2
Levofloxacin Injection 2 records · Latest accepted 2026/03/20
Supplement · 1Generic · 1
Ambroxol Hydrochloride Injection 1 records · Latest accepted 2026/03/20
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600548 | Supplement | 2026/03/20 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
No verified English name 1 records · Latest accepted 2026/03/13
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600512 | Supplement | 2026/03/13 | CISEN PHARMACEUTICAL CO., LTD.; Henan Ke Lun Pharma Co., Ltd. romanized | CDE ↗ |
Vitamin K1 Injection 1 records · Latest accepted 2026/02/28
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2650068 | Supplement | 2026/02/28 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
No verified English name 1 records · Latest accepted 2026/02/07
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600408 | Generic | 2026/02/07 | CISEN PHARMACEUTICAL CO., LTD.; Guangzhou Bo Si Tao Kong Shi Pharma Co., Ltd. romanized | CDE ↗ |
Sodium Bicarbonate Injection 3 records · Latest accepted 2026/02/02
Supplement · 3
Sodium Acetate Ringer's Injection 1 records · Latest accepted 2026/01/16
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600203 | Generic | 2026/01/16 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
No verified English name 1 records · Latest accepted 2025/12/12
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2504261 | Generic | 2025/12/12 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
No verified English name 2 records · Latest accepted 2025/12/09
Generic · 2
Nadroparin Calcium Injection 2 records · Latest accepted 2025/11/13
Generic · 2
Pregabalin Capsules 2 records · Latest accepted 2025/10/29
Generic · 2
Pemafibrate Tablets 1 records · Latest accepted 2025/10/14
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503655 | Generic | 2025/10/14 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
No verified English name 1 records · Latest accepted 2025/10/14
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503657 | Generic | 2025/10/14 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Norepinephrine Bitartrate Injection 1 records · Latest accepted 2025/09/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503325 | Generic | 2025/09/08 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Ondansetron Hydrochloride Tablets 2 records · Latest accepted 2025/09/02
Generic · 2
Isoprenaline Hydrochloride Injection 2 records · Latest accepted 2025/08/27
Generic · 2
No verified English name 1 records · Latest accepted 2025/08/19
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503034 | Generic | 2025/08/19 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Pantoprazole Sodium For Injection 1 records · Latest accepted 2025/08/13
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2550289 | Supplement | 2025/08/13 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
No verified English name 1 records · Latest accepted 2025/08/11
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502906 | Generic | 2025/08/11 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
No verified English name 1 records · Latest accepted 2025/08/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502867 | Generic | 2025/08/08 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
No verified English name 1 records · Latest accepted 2025/08/05
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502823 | Generic | 2025/08/05 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Iguratimod Tablets 1 records · Latest accepted 2025/07/31
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502756 | Generic | 2025/07/31 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Propofol Medium And Long Chain Fat Emulsion Injection 2 records · Latest accepted 2025/07/23
Generic · 2
Ilaprazole Enteric-coated Tablets 1 records · Latest accepted 2025/07/18
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502594 | Generic | 2025/07/18 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Edoxaban Tosilate Tablets 2 records · Latest accepted 2025/07/01
Supplement · 1Generic · 1
No verified English name 1 records · Latest accepted 2025/06/21
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502233 | Generic | 2025/06/21 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
No verified English name 2 records · Latest accepted 2025/05/31
Supplement · 2
No verified English name 4 records · Latest accepted 2025/05/29
Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2501102 | Supplement | 2025/05/29 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| CYHB2501101 | Supplement | 2025/05/29 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| CYHB2401694 | Supplement | 2024/10/24 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| CYHB2401318 | Supplement | 2024/08/24 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
No verified English name 4 records · Latest accepted 2025/05/20
Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2501023 | Supplement | 2025/05/20 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| CYHB2501022 | Supplement | 2025/05/20 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| CYHB2501019 | Supplement | 2025/05/19 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| CYHB2501018 | Supplement | 2025/05/19 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
No verified English name 1 records · Latest accepted 2025/05/16
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501790 | Generic | 2025/05/16 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Metoprolol Tartrate Injection 1 records · Latest accepted 2025/04/28
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2550181 | Supplement | 2025/04/28 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Hydrochlorothiazide Tablets 1 records · Latest accepted 2025/03/27
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2550159 | Supplement | 2025/03/27 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Azithromycin Tablets 1 records · Latest accepted 2025/03/21
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501141 | Generic | 2025/03/21 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Metronidazole Tablets 1 records · Latest accepted 2025/02/21
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2550122 | Supplement | 2025/02/21 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
No verified English name 1 records · Latest accepted 2025/02/09
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500679 | Generic | 2025/02/09 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
No verified English name 1 records · Latest accepted 2025/02/09
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500680 | Generic | 2025/02/09 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Lincomycin Injection 1 records · Latest accepted 2025/02/09
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2550102 | Supplement | 2025/02/09 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Paliperidone Extend-release Tablets 1 records · Latest accepted 2025/01/27
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500531 | Generic | 2025/01/27 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
No verified English name 1 records · Latest accepted 2025/01/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500217 | Generic | 2025/01/10 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
No verified English name 1 records · Latest accepted 2025/01/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500219 | Generic | 2025/01/10 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Ondansetron Hydrochloride Injection 2 records · Latest accepted 2024/12/10
Supplement · 2
Potassium Phosphates Injection 1 records · Latest accepted 2024/11/29
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2404107 | Generic | 2024/11/29 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
No verified English name 1 records · Latest accepted 2024/11/23
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2404026 | Generic | 2024/11/23 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Lamotrigine Tablets 2 records · Latest accepted 2024/11/21
Generic · 2
Moxifloxacin Hydrochloride Tablets 1 records · Latest accepted 2024/11/09
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403827 | Generic | 2024/11/09 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
No verified English name 1 records · Latest accepted 2024/11/01
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401769 | Supplement | 2024/11/01 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Bumetanide Injection 1 records · Latest accepted 2024/10/18
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403533 | Generic | 2024/10/18 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅰ) 1 records · Latest accepted 2024/10/12
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403409 | Generic | 2024/10/12 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
No verified English name 1 records · Latest accepted 2024/10/12
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403410 | Generic | 2024/10/12 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Dapagliflozin Tablets 4 records · Latest accepted 2024/10/12
Generic · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403390 | Generic | 2024/10/12 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| CYHS2403389 | Generic | 2024/10/12 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| CYHS2301291 | Generic | 2023/05/12 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| CYHS2301289 | Generic | 2023/05/12 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
No verified English name 3 records · Latest accepted 2024/09/26
Supplement · 1New drug · 2
No verified English name 1 records · Latest accepted 2024/08/30
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402834 | Generic | 2024/08/30 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
No verified English name 1 records · Latest accepted 2024/08/24
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401317 | Supplement | 2024/08/24 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
No verified English name 1 records · Latest accepted 2024/08/24
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401315 | Supplement | 2024/08/24 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Tramadol Hydrochloride Injection 1 records · Latest accepted 2024/08/20
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2450436 | Supplement | 2024/08/20 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Brexpiprazole Tablets 2 records · Latest accepted 2024/08/13
Generic · 2
No verified English name 3 records · Latest accepted 2024/07/20
Supplement · 1New drug · 2
Ciprofloxacin Lactate and Sodium Chloride Injection 1 records · Latest accepted 2024/07/15
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2450377 | Supplement | 2024/07/15 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
No verified English name 2 records · Latest accepted 2024/07/04
Generic · 2
Brivaracetam Tablets 3 records · Latest accepted 2024/06/19
Generic · 3
Levofloxacin and Sodium Chloride Injection 2 records · Latest accepted 2024/06/18
Supplement · 1Generic · 1
Lactated Ringer's Injection 1 records · Latest accepted 2024/06/15
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2450326 | Supplement | 2024/06/15 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
No verified English name 1 records · Latest accepted 2024/06/12
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2400800 | Supplement | 2024/06/12 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Fluvoxamine Maleate Tablets 1 records · Latest accepted 2024/05/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401386 | Generic | 2024/05/10 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Bromhexine Hydrochloride Injection 1 records · Latest accepted 2024/04/30
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401309 | Generic | 2024/04/30 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Clopidogrel Bisulfate and Aspirin Tablets 1 records · Latest accepted 2024/04/29
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401291 | Generic | 2024/04/29 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Dalteparin Sodium Injection 2 records · Latest accepted 2024/04/24
Generic · 2
Naloxone Hydrochloride Injection 1 records · Latest accepted 2024/04/17
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401135 | Generic | 2024/04/17 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Multiple Electrolytes Injection（Ⅱ） 2 records · Latest accepted 2024/04/09
Generic · 2
Ganirelix Injection 1 records · Latest accepted 2024/03/29
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400951 | Generic | 2024/03/29 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Multiple Electrolyte Additive For Injection 1 records · Latest accepted 2024/03/13
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400820 | Generic | 2024/03/13 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Pentoxifylline Injection 1 records · Latest accepted 2024/02/05
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400498 | Generic | 2024/02/05 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Fenofibrate Capsules 2 records · Latest accepted 2024/02/02
Supplement · 1Generic · 1
No verified English name 1 records · Latest accepted 2024/01/26
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400353 | Generic | 2024/01/26 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Glycerol Fructose And Sodium Chloride Injection 2 records · Latest accepted 2024/01/04
Supplement · 1Generic · 1
Felodipine Sustained Release Tablets 1 records · Latest accepted 2023/12/29
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2303670 | Generic | 2023/12/29 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Fluconazole and Sodium Chloride Injection 1 records · Latest accepted 2023/11/21
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350856 | Supplement | 2023/11/21 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Enoxaparin Sodium Injection 4 records · Latest accepted 2023/10/27
Supplement · 2Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2302367 | Supplement | 2023/10/27 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| CYHB2302366 | Supplement | 2023/10/27 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| CYHS2101513 | Generic | 2021/08/05 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| CYHS2101512 | Generic | 2021/08/05 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Rabeprazole Sodium Enteric-coated Tablets 1 records · Latest accepted 2023/10/24
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302867 | Generic | 2023/10/24 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Dexamethasone Acetate Tablets 1 records · Latest accepted 2023/09/26
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350733 | Supplement | 2023/09/26 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Betamethasone Sodium Phosphate Injection 1 records · Latest accepted 2023/09/23
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302577 | Generic | 2023/09/23 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Isosorbide Dinitrate Injection 1 records · Latest accepted 2023/09/12
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302455 | Generic | 2023/09/12 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
No verified English name 1 records · Latest accepted 2023/09/06
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302392 | Generic | 2023/09/06 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Docetaxel Injection 4 records · Latest accepted 2023/09/02
Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2301976 | Supplement | 2023/09/02 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| CYHB2301975 | Supplement | 2023/09/02 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| CYHB2301974 | Supplement | 2023/09/02 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| CYHB2301973 | Supplement | 2023/09/02 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
No verified English name 5 records · Latest accepted 2023/08/19
New drug · 5
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2300895 | New drug | 2023/08/19 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| CXHL2300894 | New drug | 2023/08/19 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| CXHL2101130 | New drug | 2021/05/17 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| CXHL2101129 | New drug | 2021/05/17 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| CXHL2101128 | New drug | 2021/05/17 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Tacrolimus Sustained-release Capsules 2 records · Latest accepted 2023/07/25
Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2301980 | Generic | 2023/07/25 | CISEN PHARMACEUTICAL CO., LTD.; Hua Yi Tai Kang Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2301979 | Generic | 2023/07/25 | CISEN PHARMACEUTICAL CO., LTD.; Hua Yi Tai Kang Pharma Co., Ltd. romanized | CDE ↗ |
Metronidazole and Sodium Chloride Injection 2 records · Latest accepted 2023/07/21
Supplement · 2
Mesalazine Enteric-coated Tablets 1 records · Latest accepted 2023/07/13
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2301886 | Generic | 2023/07/13 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
IsosorbideMononitrate Tablets 1 records · Latest accepted 2023/07/11
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350549 | Supplement | 2023/07/11 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Famotidine Injection 1 records · Latest accepted 2023/07/01
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350515 | Supplement | 2023/07/01 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
No verified English name 1 records · Latest accepted 2023/04/25
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2300429 | New drug | 2023/04/25 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
No verified English name 1 records · Latest accepted 2023/02/13
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2300277 | Supplement | 2023/02/13 | CISEN PHARMACEUTICAL CO., LTD.; Anhui Huan Qiu Pharma Co., Ltd. romanized | CDE ↗ |
No verified English name 1 records · Latest accepted 2023/02/11
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2300256 | Supplement | 2023/02/11 | CISEN PHARMACEUTICAL CO., LTD.; Anhui Huan Qiu Pharma Co., Ltd. romanized | CDE ↗ |
Metoprolol Succinate Extended-release Capsules 2 records · Latest accepted 2023/01/12
Generic · 2
Fesoterodine Fumarate Prolonged-Release Tablets 2 records · Latest accepted 2023/01/03
Generic · 2
No verified English name 1 records · Latest accepted 2022/12/09
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2250747 | Supplement | 2022/12/09 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
No verified English name 1 records · Latest accepted 2022/11/12
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2202068 | Supplement | 2022/11/12 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Desmopressin Acetate Injection 2 records · Latest accepted 2022/11/10
Generic · 2
No verified English name 1 records · Latest accepted 2022/10/12
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201704 | Generic | 2022/10/12 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Vortioxetine Hydrobromide Tablets 2 records · Latest accepted 2022/08/29
Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201400 | Generic | 2022/08/29 | CISEN PHARMACEUTICAL CO., LTD.; Guangzhou Bo Si Tao Kong Shi Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2201399 | Generic | 2022/08/29 | CISEN PHARMACEUTICAL CO., LTD.; Guangzhou Bo Si Tao Kong Shi Pharma Co., Ltd. romanized | CDE ↗ |
No verified English name 1 records · Latest accepted 2022/08/26
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2250535 | Supplement | 2022/08/26 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Sodium Bicarbonate Ringer’s Injection 1 records · Latest accepted 2022/08/25
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201376 | Generic | 2022/08/25 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
No verified English name 2 records · Latest accepted 2022/07/22
New drug · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2200522 | New drug | 2022/07/22 | CISEN PHARMACEUTICAL CO., LTD.; Tianjin Chen Xin Drug Research Co., Ltd. romanized | CDE ↗ |
| CXHL2200521 | New drug | 2022/07/22 | CISEN PHARMACEUTICAL CO., LTD.; Tianjin Chen Xin Drug Research Co., Ltd. romanized | CDE ↗ |
No verified English name 1 records · Latest accepted 2022/07/02
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200986 | Generic | 2022/07/02 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Mecobalamin Injection 1 records · Latest accepted 2022/05/05
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2250253 | Supplement | 2022/05/05 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Moxifloxacin Hydrochloride And Sodium Chloride Injection 1 records · Latest accepted 2022/04/19
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200616 | Generic | 2022/04/19 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
No verified English name 1 records · Latest accepted 2022/02/21
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200357 | Generic | 2022/02/21 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Carbetocin Injection 1 records · Latest accepted 2022/01/26
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200184 | Generic | 2022/01/26 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Voglibose Tablets 1 records · Latest accepted 2022/01/17
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200076 | Generic | 2022/01/17 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Lurasidone Hydrochloride Tablets 1 records · Latest accepted 2021/12/28
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2102298 | Generic | 2021/12/28 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Bromfenac Sodium Eye Drops 1 records · Latest accepted 2021/12/24
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2102280 | Generic | 2021/12/24 | CISEN PHARMACEUTICAL CO., LTD.; Shandong Chen Xin Fu Dou Pharma Co., Ltd. romanized | CDE ↗ |
Valsartan and Amlodipine Tablets（I） 1 records · Latest accepted 2021/08/12
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101568 | Generic | 2021/08/12 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Mecobalamin Tablets 1 records · Latest accepted 2021/06/25
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2150687 | Supplement | 2021/06/25 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Citicoline Sodium Injection 1 records · Latest accepted 2021/06/04
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101242 | Generic | 2021/06/04 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
No verified English name 1 records · Latest accepted 2021/04/27
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2101176 | Supplement | 2021/04/27 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Tenofovir alafenamide Fumarate Tablets 1 records · Latest accepted 2021/04/14
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101056 | Generic | 2021/04/14 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Alanyl Glutamine Injection 2 records · Latest accepted 2021/03/09
Supplement · 2
Teriflunomide Tablets 1 records · Latest accepted 2021/03/09
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2100262 | Generic | 2021/03/09 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Dexamethasone Sodium Phosphate Injection 1 records · Latest accepted 2021/03/03
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2150139 | Supplement | 2021/03/03 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Valsartan and Hydrochlorothiazide Tablets 1 records · Latest accepted 2021/03/02
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2100247 | Generic | 2021/03/02 | CISEN PHARMACEUTICAL CO., LTD.; Hainan Hua Yi Tai Kang Pharma Co., Ltd. romanized | CDE ↗ |
Dexmedetomidine Hydrochloride Injection 1 records · Latest accepted 2021/01/21
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2100089 | Generic | 2021/01/21 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Changes in the last 90 days
8 events from 2026/08/14 to 2026/11/11. CDE data as of 2026/11/11 06:42; NMPA data as of 2026/11/10 18:31.
This source was last successfully updated at 2026/11/10 18:31; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Marketing application approved: 2 applicationsAccepted: 6 applications
- 2026/11/03Marketing application approved
Ilaprazole Enteric-coated Tablets
CYHS2502594 · 国药准字H20266477
Fact date: 2026/11/03 · Publication date: 2026/11/05 · Site observation date: 2026/11/06
View source · Table row 98 ↗ - 2026/10/26Marketing application approved
No verified English name
CYHS2502233 · 国药准字H20266422
Fact date: 2026/10/26 · Publication date: 2026/10/27 · Site observation date: 2026/11/03
View source · Table row 51 ↗ - 2026/10/21Accepted
Adefovir Dipivoxil Tablets
CYHB2601915
Fact date: 2026/10/21 · Site observation date: 2026/10/22
View source ↗ - 2026/09/18Accepted
Pioglitazone Hydrochloride Tablets
CYHS2602331
Fact date: 2026/09/18 · Site observation date: 2026/10/22
View source ↗ - 2026/09/18Accepted
Pioglitazone Hydrochloride Tablets
CYHS2602330
Fact date: 2026/09/18 · Site observation date: 2026/10/22
View source ↗ - 2026/09/17Accepted
Tranexamic Acid Injection
CYHS2602320
Fact date: 2026/09/17 · Site observation date: 2026/10/22
View source ↗ - 2026/09/17Accepted
Tranexamic Acid Injection
CYHS2602319
Fact date: 2026/09/17 · Site observation date: 2026/10/22
View source ↗ - 2026/08/20Accepted
Loratadine Tablets
CYHS2602061
Fact date: 2026/08/20 · Site observation date: 2026/10/22
View source ↗
Under review
50 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/11 06:42.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Adefovir Dipivoxil Tablets | CYHB2601915 | Supplement | 2026/10/21 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Pioglitazone Hydrochloride Tablets | CYHS2602331 | Generic | 2026/09/18 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Pioglitazone Hydrochloride Tablets | CYHS2602330 | Generic | 2026/09/18 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Tranexamic Acid Injection | CYHS2602320 | Generic | 2026/09/17 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Tranexamic Acid Injection | CYHS2602319 | Generic | 2026/09/17 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Loratadine Tablets | CYHS2602061 | Generic | 2026/08/20 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Iopromide Injection | CYHS2601825 | Generic | 2026/07/29 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Azithromycin For Injection | CYHB2650165 | Supplement | 2026/07/23 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| No verified English name | CYHS2601705 | Generic | 2026/07/17 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| No verified English name | CYHS2601704 | Generic | 2026/07/16 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Baricitinib Tablets | CYHS2601701 | Generic | 2026/07/16 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Baricitinib Tablets | CYHS2601700 | Generic | 2026/07/16 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Metformin Hydrochloride Tablets | CYHS2601595 | Generic | 2026/07/06 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Peramivir Injection | CYHS2601554 | Generic | 2026/07/01 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Ioversol Injection | CYHS2601458 | Generic | 2026/06/18 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Ioversol Injection | CYHS2601457 | Generic | 2026/06/18 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Isosorbide Mononitrate Extended-Release Tablets | CYHS2601170 | Generic | 2026/05/18 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Iomeprol Injection | CYHS2601074 | Generic | 2026/05/11 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Ambroxol Hydrochloride Tablets | CYHS2601025 | Generic | 2026/05/06 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Multiple Electrolytes Injection | CYHS2600897 | Generic | 2026/04/20 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Carboplatin Injection | CYHS2600782 | Generic | 2026/04/03 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Carboplatin Injection | CYHS2600781 | Generic | 2026/04/03 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Selexipag Tablets | CYHS2600693 | Generic | 2026/03/20 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Selexipag Tablets | CYHS2600692 | Generic | 2026/03/20 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Vitamin K1 Injection | CYHB2650068 | Supplement | 2026/02/28 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| No verified English name | CYHS2600408 | Generic | 2026/02/07 | CISEN PHARMACEUTICAL CO., LTD.; Guangzhou Bo Si Tao Kong Shi Pharma Co., Ltd. romanized | CDE ↗ |
| Sodium Bicarbonate Injection | CYHB2650037 | Supplement | 2026/02/02 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Sodium Acetate Ringer's Injection | CYHS2600203 | Generic | 2026/01/16 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| No verified English name | CYHS2504261 | Generic | 2025/12/12 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| No verified English name | CYHS2504220 | Generic | 2025/12/09 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| No verified English name | CYHS2504219 | Generic | 2025/12/09 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Nadroparin Calcium Injection | CYHS2503954 | Generic | 2025/11/13 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Nadroparin Calcium Injection | CYHS2503953 | Generic | 2025/11/13 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Sodium Bicarbonate Injection | CYHB2550361 | Supplement | 2025/11/11 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Sodium Bicarbonate Injection | CYHB2550360 | Supplement | 2025/11/11 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Pregabalin Capsules | CYHS2503818 | Generic | 2025/10/29 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Pregabalin Capsules | CYHS2503817 | Generic | 2025/10/29 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| No verified English name | CYHS2503657 | Generic | 2025/10/14 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Pemafibrate Tablets | CYHS2503655 | Generic | 2025/10/14 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Norepinephrine Bitartrate Injection | CYHS2503325 | Generic | 2025/09/08 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Ondansetron Hydrochloride Tablets | CYHS2503243 | Generic | 2025/09/02 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Ondansetron Hydrochloride Tablets | CYHS2503242 | Generic | 2025/09/02 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Isoprenaline Hydrochloride Injection | CYHS2503147 | Generic | 2025/08/27 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Isoprenaline Hydrochloride Injection | CYHS2503146 | Generic | 2025/08/27 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| No verified English name | CYHS2503034 | Generic | 2025/08/19 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| No verified English name | CYHS2502906 | Generic | 2025/08/11 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| No verified English name | CYHS2502867 | Generic | 2025/08/08 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| No verified English name | CYHS2502823 | Generic | 2025/08/05 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Propofol Medium And Long Chain Fat Emulsion Injection | CYHS2502652 | Generic | 2025/07/23 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Propofol Medium And Long Chain Fat Emulsion Injection | CYHS2502651 | Generic | 2025/07/23 | CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
Catalogue holder records
100 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/11 06:38. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| No verified English name | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20265790 | 2026/09/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20265791 | 2026/09/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20265634 | 2026/08/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20265633 | 2026/08/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20265538 | 2026/08/04 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Pantoprazole Sodium For Injection | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20073977 | 2026/07/28 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Levofloxacin Injection | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20269138 | 2026/06/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Azithromycin Tablets | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20264567 | 2026/05/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Paliperidone Extend-release Tablets | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20264364 | 2026/05/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Potassium Phosphates Injection | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20264175 | 2026/04/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20264127 | 2026/04/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅰ) | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20264126 | 2026/04/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dapagliflozin Tablets | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20263949 | 2026/04/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dapagliflozin Tablets | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20263950 | 2026/04/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Bumetanide Injection | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20263951 | 2026/04/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Metoprolol Tartrate Injection | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20013312 | 2026/04/03 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Moxifloxacin Hydrochloride Tablets | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20263789 | 2026/03/31 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lamotrigine Tablets | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20263440 | 2026/02/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lamotrigine Tablets | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20263441 | 2026/02/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Metronidazole Tablets | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H37021903 | 2026/01/16 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| No verified English name | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20263087 | 2026/01/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20263086 | 2026/01/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Hydrochlorothiazide Tablets | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H37021905 | 2025/12/31 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Brexpiprazole Tablets | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20256271 | 2025/12/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Brexpiprazole Tablets | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20256272 | 2025/12/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lincomycin Injection | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H37021974 | 2025/12/05 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Levofloxacin Injection | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20255993 | 2025/11/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20255774 | 2025/10/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Naloxone Hydrochloride Injection | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20255653 | 2025/09/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Clopidogrel Bisulfate and Aspirin Tablets | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20255573 | 2025/09/23 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ondansetron Hydrochloride Injection | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20067242 | 2025/09/22 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ondansetron Hydrochloride Injection | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20067241 | 2025/09/22 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| No verified English name | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20255281 | 2025/09/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Bromhexine Hydrochloride Injection | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20255075 | 2025/07/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ciprofloxacin Lactate and Sodium Chloride Injection | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20043198 | 2025/07/24 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ganirelix Injection | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20254901 | 2025/07/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tramadol Hydrochloride Injection | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20013151 | 2025/07/07 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Multiple Electrolytes Injection（Ⅱ） | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20254649 | 2025/06/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Multiple Electrolyte Additive For Injection | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20254632 | 2025/06/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Fluvoxamine Maleate Tablets | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20254658 | 2025/06/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Multiple Electrolytes Injection（Ⅱ） | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20254648 | 2025/06/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Pentoxifylline Injection | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20254570 | 2025/06/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dalteparin Sodium Injection | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20254555 | 2025/06/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dalteparin Sodium Injection | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20254554 | 2025/06/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Felodipine Sustained Release Tablets | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20254417 | 2025/06/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Mesalazine Enteric-coated Tablets | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20254450 | 2025/06/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Betamethasone Sodium Phosphate Injection | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20254363 | 2025/05/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lactated Ringer's Injection | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20057107 | 2025/04/29 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Rabeprazole Sodium Enteric-coated Tablets | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20253903 | 2025/04/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tacrolimus Sustained-release Capsules | CISEN PHARMACEUTICAL CO., LTD. | Hua Yi Tai Kang Pharma Co., Ltd. romanized | 国药准字H20253242 | 2025/01/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tacrolimus Sustained-release Capsules | CISEN PHARMACEUTICAL CO., LTD. | Hua Yi Tai Kang Pharma Co., Ltd. romanized | 国药准字H20253241 | 2025/01/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20253187 | 2025/01/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Isosorbide Dinitrate Injection | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20249434 | 2024/11/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Edoxaban Tosilate Tablets | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20249411 | 2024/11/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Fluconazole and Sodium Chloride Injection | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20023151 | 2024/10/30 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Dexamethasone Acetate Tablets | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H37021898 | 2024/07/09 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Teriflunomide Tablets | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20244038 | 2024/06/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20244082 | 2024/06/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20244083 | 2024/06/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20243986 | 2024/06/11 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| IsosorbideMononitrate Tablets | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20066014 | 2024/06/07 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Famotidine Injection | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20067499 | 2024/05/20 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Metoprolol Succinate Extended-release Capsules | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20243717 | 2024/05/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Metoprolol Succinate Extended-release Capsules | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20243716 | 2024/05/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Moxifloxacin Hydrochloride And Sodium Chloride Injection | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20243417 | 2024/03/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Vortioxetine Hydrobromide Tablets | CISEN PHARMACEUTICAL CO., LTD. | Guangzhou Bo Si Tao Kong Shi Pharma Co., Ltd. romanized | 国药准字H20243147 | 2024/02/06 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lurasidone Hydrochloride Tablets | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20243172 | 2024/02/06 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Vortioxetine Hydrobromide Tablets | CISEN PHARMACEUTICAL CO., LTD. | Guangzhou Bo Si Tao Kong Shi Pharma Co., Ltd. romanized | 国药准字H20243148 | 2024/02/06 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sodium Bicarbonate Ringer’s Injection | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20234702 | 2023/12/26 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20103095 | 2023/11/28 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| No verified English name | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20234526 | 2023/11/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Fenofibrate Capsules | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20234311 | 2023/10/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Levofloxacin and Sodium Chloride Injection | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20234286 | 2023/10/12 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20234180 | 2023/09/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Voglibose Tablets | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20233588 | 2023/05/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Carbetocin Injection | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20233591 | 2023/05/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Potassium Chloride Injection | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20184024 | 2023/05/04 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Glycerol Fructose And Sodium Chloride Injection | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20233434 | 2023/04/11 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Citicoline Sodium Injection | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20233291 | 2023/03/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Mecobalamin Injection | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20055734 | 2022/12/29 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Mecobalamin Tablets | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20051425 | 2022/11/02 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Enoxaparin Sodium Injection | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20223798 | 2022/11/01 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Valsartan and Amlodipine Tablets（I） | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20223801 | 2022/11/01 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Enoxaparin Sodium Injection | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20223799 | 2022/11/01 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Esomeprazole Magnesium Enteric-Coated Capsules | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20223565 | 2022/08/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Esomeprazole Magnesium Enteric-Coated Capsules | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20223566 | 2022/08/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Metronidazole and Sodium Chloride Injection | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20013146 | 2022/07/07 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Valsartan and Hydrochlorothiazide Tablets | CISEN PHARMACEUTICAL CO., LTD. | Hua Yi Tai Kang Pharma Co., Ltd. romanized | 国药准字H20223460 | 2022/06/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Adefovir Dipivoxil Tablets | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20080034 | 2022/05/16 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Dexamethasone Sodium Phosphate Injection | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H37021969 | 2022/01/24 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Alanyl Glutamine Injection | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20053876 | 2022/01/12 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Alanyl Glutamine Injection | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20053877 | 2022/01/12 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Levofloxacin Tablets | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20223004 | 2022/01/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Clindamycin Injection | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20046006 | 2021/10/21 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Sitagliptin Phosphate Tablets | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20213759 | 2021/09/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Aspirin Enteric-coated Tablets | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20113013 | 2021/08/12 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Metformin Hydrochloride Extended-release Tablets | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20213623 | 2021/07/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ambroxol Hydrochloride Injection | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20163049 | 2021/03/10 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Dexmedetomidine Hydrochloride Injection | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20130027 | 2021/03/04 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| No verified English name | CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20063064 | 2023/11/28 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
15 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/11 06:40.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| No verified English name | CISEN PHARMACEUTICAL CO., LTD. | Y20190006657 | A | — | CDE ↗ |
| No verified English name | CISEN PHARMACEUTICAL CO., LTD. | Y20170001473 | I | — | CDE ↗ |
| No verified English name | CISEN PHARMACEUTICAL CO., LTD. | Y20170001295 | I | — | CDE ↗ |
| No verified English name | CISEN PHARMACEUTICAL CO., LTD. | Y20170001294 | I | — | CDE ↗ |
| No verified English name | CISEN PHARMACEUTICAL CO., LTD. | Y20170001246 | I | — | CDE ↗ |
| No verified English name | CISEN PHARMACEUTICAL CO., LTD. | Y20170001074 | I | — | CDE ↗ |
| No verified English name | CISEN PHARMACEUTICAL CO., LTD. | Y20170001073 | I | — | CDE ↗ |
| No verified English name | CISEN PHARMACEUTICAL CO., LTD. | Y20170001032 | I | — | CDE ↗ |
| No verified English name | CISEN PHARMACEUTICAL CO., LTD. | Y20170001031 | I | — | CDE ↗ |
| No verified English name | CISEN PHARMACEUTICAL CO., LTD. | Y20170000756 | I | — | CDE ↗ |
| No verified English name | CISEN PHARMACEUTICAL CO., LTD. | Y20170000637 | I | — | CDE ↗ |
| No verified English name | CISEN PHARMACEUTICAL CO., LTD. | Y20170000521 | I | — | CDE ↗ |
| No verified English name | CISEN PHARMACEUTICAL CO., LTD. | Y20170000506 | I | — | CDE ↗ |
| No verified English name | CISEN PHARMACEUTICAL CO., LTD. | Y20170000479 | I | — | CDE ↗ |
| No verified English name | CISEN PHARMACEUTICAL CO., LTD. | Y20170000469 | I | — | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
20 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/11 06:42.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Amikacin Sulfate injection | CYHB2600732 | Supplement | 2026/04/11 | Shandong Chen Xin Fu Dou Pharma Co., Ltd. romanized; CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| No verified English name | CYHS2504209 | Generic | 2025/12/06 | Nanjing En Tai Pharmaceuticals Technology Co., Ltd. romanized; CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| No verified English name | CYHS2504207 | Generic | 2025/12/06 | Nanjing En Tai Pharmaceuticals Technology Co., Ltd. romanized; CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Mepivacaine Hydrochloride Injection | CYHB2501684 | Supplement | 2025/08/25 | Shandong Chen Xin Fu Dou Pharma Co., Ltd. romanized; CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Calcium Gluconate Injection | CYHB2500573 | Supplement | 2025/03/20 | Shandong Chen Xin Fu Dou Pharma Co., Ltd. romanized; CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Mepivacaine Hydrochloride Injection | CYHB2500566 | Supplement | 2025/03/20 | Shandong Chen Xin Fu Dou Pharma Co., Ltd. romanized; CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Citicoline Sodium Injection | CYHB2450455 | Supplement | 2024/08/29 | Jinan Chen Xin Pharmaceuticals Technology Co., Ltd. romanized; CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Azithromycin Tablets | CYHB2401114 | Supplement | 2024/07/26 | Shandong Yi Jian Pharma Co., Ltd. romanized; CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Azithromycin Tablets | CYHB2401113 | Supplement | 2024/07/26 | Shandong Yi Jian Pharma Co., Ltd. romanized; CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Domperidone Tablets | CYHB2401112 | Supplement | 2024/07/26 | Shandong Yi Jian Pharma Co., Ltd. romanized; CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Citicoline Sodium Injection | CYHB2401089 | Supplement | 2024/07/20 | Jinan Chen Xin Pharmaceuticals Technology Co., Ltd. romanized; CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Amikacin Sulfate injection | CYHS2400146 | Generic | 2024/01/10 | Jinan Chen Xin Pharmaceuticals Technology Co., Ltd. romanized; CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Fenofibrate Capsules | CYHB2301215 | Supplement | 2023/05/27 | Jinan Chen Xin Pharmaceuticals Technology Co., Ltd. romanized; CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Citicoline Sodium Injection | CYHB2301176 | Supplement | 2023/05/23 | Jinan Chen Xin Pharmaceuticals Technology Co., Ltd. romanized; CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Mepivacaine Hydrochloride Injection | CYHS2301195 | Generic | 2023/04/29 | Jinan Chen Xin Pharmaceuticals Technology Co., Ltd. romanized; CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Citicoline Sodium Injection | CYHB2300829 | Supplement | 2023/04/20 | Jinan Chen Xin Pharmaceuticals Technology Co., Ltd. romanized; CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Calcium Gluconate Injection | CYHS2300877 | Generic | 2023/03/24 | Jinan Chen Xin Pharmaceuticals Technology Co., Ltd. romanized; CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| No verified English name | CYHS2202084 | Generic | 2022/12/20 | Jinan Chen Xin Pharmaceuticals Technology Co., Ltd. romanized; CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| No verified English name | JTH2200230 | Not stated by source | 2022/11/16 | MSN Organics Private Limited; CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Acetylcysteine Solution For Inhalation | CYHS2201375 | Generic | 2022/08/24 | Chongqing Zhong Chuang Ke Pharmaceuticals Co., Ltd. romanized; CISEN PHARMACEUTICAL CO., LTD. | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/11 06:42
- Chemical-drug catalogue
- Last successful update: 2026/11/11 06:38
- Full API register
- Last successful update: 2026/11/11 06:40
- NMPA drug delivery notices
- Last successful update: 2026/11/10 18:31 · Current coverage may be incomplete
First index-page publication dates: — to —; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only, without new source queries or collection. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Drug names use verified official English names only. Missing names are shown as No verified English name, linking to a Chinese page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized. Original statutory reference numbers are the sole visible Chinese exception.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Chinese free text is not displayed; use the source links or source-name columns in CSV exports.